Table of Contents
Financial Overview
Baxter 2001 Financial Highlights
Total Shareholder Returns in 2001
Baxter Shareholder Return (1993 – 2001)
Baxter Portfolio
2001 Baxter Portfolio
Operational Excellence (1993 – 2001)
Sales Growth and Margin Expansion
Gross Margin Expansion
Gross Margin Expansion
Gross Margin Expansion
Gross Margin Expansion
Financial Strength and Flexibility
Financial Strength and Flexibility
Financial Strength and Flexibility
Gross Margin Expansion and SG&A Leverage Will Fund Increased R&D Investments
2001 R & D Accomplishments
2002 Clinical Milestones
2002 Expected Approvals and Launches
Baxter 2002 Financial Outlook
Accelerating Growth
Accelerating Growth
Summary
|